GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Inventage Lab Inc (XKRX:389470) » Definitions » Common Stock

Inventage Lab (XKRX:389470) Common Stock : ₩0.0 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Inventage Lab Common Stock?

Inventage Lab's quarterly common stock increased from Sep. 2023 (₩4,209.3 Mil) to Dec. 2023 (₩4,226.8 Mil) but then declined from Dec. 2023 (₩4,226.8 Mil) to Mar. 2024 (₩0.0 Mil).

Inventage Lab's annual common stock increased from Dec. 2021 (₩3,567.1 Mil) to Dec. 2022 (₩4,175.7 Mil) and increased from Dec. 2022 (₩4,175.7 Mil) to Dec. 2023 (₩4,226.8 Mil).


Inventage Lab Common Stock Historical Data

The historical data trend for Inventage Lab's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inventage Lab Common Stock Chart

Inventage Lab Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
1,306.73 3,208.27 3,567.07 4,175.67 4,226.78

Inventage Lab Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,183.28 4,202.78 4,209.28 4,226.78 -

Inventage Lab Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Inventage Lab (XKRX:389470) Business Description

Traded in Other Exchanges
N/A
Address
24, Dunchon-daero 388 beon-gil, 612, Woolim Lions Valley 3, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR, 13403
Inventage Lab Inc operates medical technology development businesses. It engages in the development of an innovative Drug Delivery System (DDS). It has developed Laminar FluiDigm, a microfluidics-based novel platform technology that builds the foundation for IVL- DrugFluidic and IVL-GeneFluidic, which are specific platform technologies used for developing and manufacturing long-acting injectables and gene-delivery therapeutics.

Inventage Lab (XKRX:389470) Headlines

No Headlines